Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-299809
Filing Date
2011-11-07
Accepted
2011-11-07 16:17:08
Documents
9
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d248839d10q.htm 10-Q 674126
2 SECTION 302 CEO CERTIFICATION d248839dex311.htm EX-31.1 6363
3 SECTION 302 CFO CERTIFICATION d248839dex312.htm EX-31.2 6484
4 SECTION 906 CEO AND CFO CERTIFICATION d248839dex321.htm EX-32.1 4621
  Complete submission text file 0001193125-11-299809.txt   2286390

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT alxa-20110930.xml EX-101.INS 302472
6 XBRL TAXONOMY EXTENSION SCHEMA alxa-20110930.xsd EX-101.SCH 12498
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alxa-20110930_cal.xml EX-101.CAL 38868
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxa-20110930_lab.xml EX-101.LAB 116910
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxa-20110930_pre.xml EX-101.PRE 69140
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

EIN.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51820 | Film No.: 111184839
SIC: 2834 Pharmaceutical Preparations